Skip to main content

Table 3 Changes in bronchiectasis severity index of 31 patients between the time of entry into the non-NTM bronchiectasis cohort and the time at the diagnosis of NTM-PD

From: New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes

n = 31

Entry of non-NTM BE cohort

Diagnosis of NTM-PD

P-value

Age, years

  

0.126

  < 50

7 (22.6)

2 (6.5)

 

 50–69

22 (71.0)

24 (77.4)

 

 70–79

2 (6.5)

5 (16.1)

 

  < 80

0

0

 

Body mass index, kg/m2

  

0.782

  < 18.5

4 (12.9)

4 (12.9)

 

 18.5–25

23 (74.2)

21 (67.7)

 

 26–29

4 (12.9)

6 (19.4)

 

 30 or more

0

0

 

FEV1, % predicted

  

0.570

  > 80

21 (67.7)

24 (77.4)

 

 50–80

10 (32.3)

7 (22.6)

 

 30–49

0

0

 

  < 30

0

0

 

Hospital admission during the last 2 years

  

0.554

 No

22 (71.0)

25 (80.9)

 

 Yes

9 (29.0)

6 (19.4)

 

Exacerbation during the last 1 year

  

0.317

 0

22 (71.0)

19 (61.3)

 

 1–2

2 (6.4)

6 (19.4)

 

 3 or more

7 (22.6)

6 (19.4)

 

MRC dyspnea score

  

> 0.999

 1–3

31 (100.0)

31 (100.0)

 

 4

0

0

 

 5

0

0

 

Pseudomonas colonization

  

> 0.999

 No

31 (100.0)

31 (100.0)

 

 Yes

0

0

 

Colonization with other organisms

  

> 0.999

 No

29 (93.5)

29 (93.5)

 

 Yes

2 (6.5)

2 (6.5)

 

3 or more lobes involved or cystic bronchiectasis

  

0.434

 No

14 (45.2)

10 (31.4)

 

 Yes

17 (54.8)

21 (67.7)

 

Bronchiectasis severity score

  

0.491

 Mild

21 (67.7)

17 (54.8)

 

 Moderate

6 (19.4)

10 (32.3)

 

 Severe

4 (12.9)

4 (12.9)

 

Total score, median [IQR]

4 [2, 7]

4 [3, 6]

0.903

  1. BE bronchiectasis, NTM-PD nontuberculous mycobacterial pulmonary disease, IQR inter-quartile range